EGFR and ERBB2 Germline Mutations in Chinese Lung Cancer Patients and Their Roles in Genetic Susceptibility to Cancer-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

EGFR and ERBB2 Germline Mutations in Chinese Lung Cancer Patients and Their Roles in Genetic Susceptibility to Cancer

Published:2019-04 Issue:4 Volume:14 Page:732-736
ISSN:1556-0864
Container-title:Journal of Thoracic Oncology
language:en
Short-container-title:Journal of Thoracic Oncology

Author:

Lu Shun,Yu Yongfeng,Li Ziming,Yu Ruoying,Wu Xue,Bao Hairong,Ding Yan,Shao Yang W.,Jian Hong

Funder

National Key R&D Program of China

National Natural Science Foundation of China

Publisher

Elsevier BV

Subject

Pulmonary and Respiratory Medicine,Oncology

Reference14 articles.

1. Genetics of lung-cancer susceptibility;Brennan;Lancet Oncol,2011

2. Family history of lung cancer in never smokers with non–small-cell lung cancer and its association with tumors harboring EGFR mutations;Gaughan;Lung Cancer,2013

3. Circulating tumor DNA mutation profiling by targeted next generation sequencing provides guidance for personalized treatments in multiple cancer types;Shu;Sci Rep,2017

4. New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada;Therasse;J Natl Cancer Inst,2000

5. Investigating novel resistance mechanisms to third-generation EGFR tyrosine kinase inhibitor osimertinib in non–small cell lung cancer patients;Yang;Clin Cancer Res,2018

Cited by 46 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Facing an un-met need in lung cancer screening: The never smokers;Critical Reviews in Oncology/Hematology;2024-10

2. Single nucleotide variants in lung cancer;Chinese Medical Journal Pulmonary and Critical Care Medicine;2024-06

3. Mutational Characteristics and Clinical Outcomes for Lung Adenocarcinoma With EGFR Germline Mutations;Journal of Thoracic Oncology;2024-06

4. Multiple primary lung cancer: Updates and perspectives;International Journal of Cancer;2024-05-23

5. Design, synthesis and bioactivity evaluation of the combination of evodiamine and erlotinib linked by indolequinone;Bioorganic & Medicinal Chemistry Letters;2024-02

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3